(877) 247-4292
Faruqi Law Blog
Categories
Latest on Facebook
Federal Judge Rules Against SEC in Blockchain ICO Case
December 12th, 2018
Judge Gonzalo Curiel of the Southern District of California recently denied the Securities and Exchange Commission’s (“SEC”) motion for a preliminary injunction against Blockvest, a Blockchain company, when he found that the SEC had not shown that Blockvest had violated US Securities Laws. The SEC’s complaint alleged that Blockvest had engaged in the unregistered sale of securities...
SEC Chairman Calls For More Detailed Brexit Disclosures
November 28th, 2018
The Wall Street Journal reports that Jay Clayton, Chairman of the United States Securities and Exchange Commission (“SEC”), recently told company controllers and accountants during a conference that the SEC “is sharpening its focus on corporate disclosures about the risks associated with the U.K.’s exit from the European Union.”. The U.K is currently scheduled to leave the EU on...
Congressional Democrats Fight for Workers’ Rights
November 5th, 2018
On October 30, 2018, Congressmen Jerrold Nadler (D-N.Y.) and Bobby Scott (D-VA) took a crucial step to combat employer’s use of arbitration agreements to restrict workers’ rights by introducing the Restore Justice for Workers Act (“Act”). The proposed legislation strives to open “the courthouse doors for workers by prohibiting the use of forced arbitration clauses in employment...
Trump Department of Justice Reverses Position on Trans Rights
November 1st, 2018
On October 25, 2018, the Department of Justice (“DOJ”), arguing on behalf of the Equal Employment Opportunity Commission (“EEOC”), contradicted the EEOC’s prior position regarding the rights of transgender employees under Title VII of the Civil Rights Act of 1964. In a brief submitted to the United States Supreme Court, the DOJ argued that federal law does not prohibit businesses...
Motion to Dismiss Opposed in Exforge Pay-for-Delay Antitrust Suit
October 26th, 2018
Faruqi & Faruqi represents a proposed class of direct purchasers of high blood pressure drug Exforge in a pay-for-delay antitrust suit against Novartis and Par Pharmaceutical. Faruqi seeks recovery of overcharges paid by wholesalers and others. The complaint alleges Novartis and Par agreed to allocate the market for Exforge, and restrict output of cheaper generic Exforge. To induce...
Find us on social networks
Twitter Facebook LinkedIn Google+